Evommune, Inc. (EVMN) is a publicly traded the market company. As of July 11, 2026, EVMN trades at $13.04 with a market cap of $486.61M and a P/E ratio of -1.18. EVMN moved -2.22% today. Year to date, EVMN is -22.84%; over the trailing twelve months it is flat. Its 52-week range spans $12.07 to $33.20. Analyst consensus is buy with an average price target of $37.60. Rallies surfaces EVMN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for EVMN, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $13.04 |
| Market Cap | $486.61M |
| P/E Ratio | -1.18 |
| EPS | $-11.22 |
| Dividend Yield | 0.00% |
| 52-Week High | $33.20 |
| 52-Week Low | $12.07 |
| Volume | 527.96K |
| Avg Volume | 0 |
| Revenue (TTM) | $13.00M |
| Net Income | $-68.87M |
| Gross Margin | 0.00% |
7 analysts cover EVMN: 0 strong buy, 5 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $37.60.